Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-6srzwwmPhase 1Recruiting
Phase 1, randomised, open-label trial in adverse drug reaction (ADR), sponsored by Universidade Federal de Alagoas. Primary endpoints: Local reaction to repeated open application of antimicrobial gel and Systemic reaction to antimicrobial gel. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-6srzwwm.